| 注册
首页|期刊导航|中国临床药理学杂志|青蒿琥酯对硼替佐米耐药的骨髓瘤细胞株增殖与凋亡的影响

青蒿琥酯对硼替佐米耐药的骨髓瘤细胞株增殖与凋亡的影响

欧瑞明 周长华 谭友平 刘爽 钟启 张青

中国临床药理学杂志2018,Vol.34Issue(10):1183-1186,4.
中国临床药理学杂志2018,Vol.34Issue(10):1183-1186,4.DOI:10.13699/j.cnki.1001-6821.2018.10.014

青蒿琥酯对硼替佐米耐药的骨髓瘤细胞株增殖与凋亡的影响

Effects of artesunate on the proliferation and apoptosis of bortezomib-resistant multiple myeloma cells

欧瑞明 1周长华 1谭友平 1刘爽 1钟启 1张青1

作者信息

  • 1. 广东省第二人民医院血液科,广州510317
  • 折叠

摘要

Abstract

Objective To explore the effects of artesunate on the proliferation,cell cycle,apoptosis and apoptosis-related protein of bortezomib-resistant multiple myeloma (MM) cells.Methods Human MM cell line NCI-H929 was treated with bortezomib in a dose-dependent manner to establish a bortezomib-resistant cell line NCI-H929BR.The logarithmic growth phase NCI-H929BR cells were divided into control group(blank culture medium)and two concentration experimental groups (artesunate,25,50 μg · mL-1)and treated for 48 h.The inhibitory role of artesunate on NCI-H929BR proliferation was measured by MTT assay.Cell apoptosis and cell cycle were determined by flow cytometry.The Bcl-2 family proteins (Bcl-2,Bcl-Xl,Bax) were detected by Western blot.Results Bortezomib resistance index of NCI-H929BR is 20.12 times than NCI -H929.After administration artesunate for 48 h,the proliferation rate of NCI-H929BR in the low and high concentration experimental groups were 62.46%,33.48%;there was significant difference compared with control group (all P<0.05).The artesunate dramatically decreases NCI-H929BR proliferation in a dose-dependent manner (P < 0.05).After treatment for 48 h with artesunate,the proportion of G1 phase cell cycle in high concentration experimental group was increased compared with control group [(51.63 ± 4.02) % vs (34.72 ± 2.43) %,P < 0.05].The proportion of apoptosis cell was increased,early apoptosis in high concentration experimental group and control group were (13.10 ± 1.53)%,(2.32 ± 1.02)%;and late apoptosis in the two groups were (10.26 ±2.42)%,(1.93 ± 0.69) %;comparison between two groups,the difference had significantly (all P < 0.05).In addition,artesunate significant decreased of Bcl-2 and Bcl-Xl protein expression and increased of Bax protein expression in a dose -dependent manner.Conclusion Artesunate could inhibit NCI-H929BR proliferation,increase apoptosis,cause G0/G1-arrest and down-regulate Bcl-2 and Bcl-Xl expression,while up-regulate Bax expression.

关键词

青蒿琥酯/硼替佐米/骨髓瘤/耐药/凋亡

Key words

artesunate/bortezomib/multiple myeloma/drug-resistance/apoptosis

分类

医药卫生

引用本文复制引用

欧瑞明,周长华,谭友平,刘爽,钟启,张青..青蒿琥酯对硼替佐米耐药的骨髓瘤细胞株增殖与凋亡的影响[J].中国临床药理学杂志,2018,34(10):1183-1186,4.

基金项目

国家自然科学基金资助项目(81400168) (81400168)

广东省中医药局科研基金资助项目(20131104) (20131104)

广东省医学科研基金资助项目(A2013128) (A2013128)

广东省第二人民医院人才引进基金资助项目(YY2014-002) (YY2014-002)

中国临床药理学杂志

OA北大核心CSCDCSTPCD

1001-6821

访问量0
|
下载量0
段落导航相关论文